NAD+ Precursors: NMN vs. NR vs. Niacin — Which One Works?
NAD+ (nicotinamide adenine dinucleotide) is arguably the most important molecule in cellular metabolism, required for over 400 enzymatic reactions and critical for DNA repair, mitochondrial function, and sirtuin activity. NAD+ levels decline with age, and boosting them has become a major focus of longevity research.
The Precursors
Three main dietary precursors can raise NAD+ levels:
| Precursor | Steps to NAD+ | Key Notes |
|---|---|---|
| Niacin (B3) | Via Preiss-Handler pathway | Causes flush, cheapest, well-proven to raise NAD+ |
| NR (Nicotinamide Riboside) | Via NR kinase pathway | No flush, multiple clinical trials, patented (Niagen) |
| NMN (Nicotinamide Mononucleotide) | One step to NAD+ | Popularized by David Sinclair's research, debated whether it enters cells directly |
Which One Works Best?
All three effectively raise blood NAD+ levels in human studies. The practical differences are: niacin is cheapest but causes flushing and may have lipid effects at high doses; NR has the most clinical trial data in humans; NMN has strong animal data and growing human evidence. There's no definitive evidence that one is clearly superior for all applications.
The question of which precursor to use is less important than whether raising NAD+ produces meaningful clinical benefits in humans. Early results are promising (improved muscle function, cardiovascular parameters, and metabolic markers), but long-term outcome data is still limited.
NAD+ is central to the function of mitochondrial nutrient pathways and connects to methylation (NAD+ is consumed by PARP enzymes during DNA repair and by sirtuins).
External resources: PubMed — NAD+ metabolism review